1. A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions. Issue 9 (9th August 2018) Authors: Franzén, Bo; Kamali‐Moghaddam, Masood; Alexeyenko, Andrey; Hatschek, Thomas; Becker, Susanne; Wik, Lotta; Kierkegaard, Jonas; Eriksson, Annika; Muppani, Naveen R.; Auer, Gert; Landegren, Ulf; Lewensohn, Rolf Journal: Molecular oncology Issue: Volume 12:Issue 9(2018) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Five-year Follow-up of Quality of Life in Women with Breast Cancer in Anthroposophic and Conventional Care. Issue 4 (2006) Authors: Carlsson, Marianne; Arman, Maria; Backman, Marie; Flatters, Ursula; Hatschek, Thomas; Hamrin, Elisabeth Journal: Evidence-based complementary and alternative medicine Issue: Volume 3:Issue 4(2006) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial. Issue 3 (13th October 2017) Authors: Kimbung, Siker; Markholm, Ida; Bjöhle, Judith; Lekberg, Tobias; von Wachenfeldt, Anna; Azavedo, Edward; Saracco, Ariel; Hellström, Mats; Veerla, Srinivas; Paquet, Eric; Bendahl, Pär‐Ola; Fernö, Mårten; Bergh, Jonas; Loman, Niklas; Hatschek, Thomas; Hedenfalk, Ingrid Journal: International journal of cancer Issue: Volume 142:Issue 3(2018) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Audio-recorded information to patients considering participation in cancer clinical trials – a randomized study. (September 2014) Authors: Bergenmar, Mia; Johansson, Hemming; Wilking, Nils; Hatschek, Thomas; Brandberg, Yvonne Journal: Acta oncologica Issue: Volume 53:Number 9(2014) Page Start: 1197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Audio-recorded information to patients considering participation in cancer clinical trials – a randomized study. (September 2014) Authors: Bergenmar, Mia; Johansson, Hemming; Wilking, Nils; Hatschek, Thomas; Brandberg, Yvonne Journal: Acta oncologica Issue: Volume 53:Number 9(2014) Page Start: 1197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences. Issue 1 (14th October 2013) Authors: Kimbung, Siker; Kovács, Anikó; Bendahl, Pär-Ola; Malmström, Per; Fernö, Mårten; Hatschek, Thomas; Hedenfalk, Ingrid Journal: Molecular oncology Issue: Volume 8:Issue 1(2014:Jan.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy. (April 2017) Authors: Saracco, Ariel; Szabó, Botond K; Tánczos, Ervin; Bergh, Jonas; Hatschek, Thomas Journal: Acta radiologica Issue: Volume 58:Number 4(2017:Apr.) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer. (2nd September 2018) Authors: Matikas, Alexios; Lövrot, John; Ramberg, Anna; Eriksson, Margareta; Lindsten, Therese; Lekberg, Tobias; Hedenfalk, Ingrid; Loman, Niklas; Bergh, Jonas; Hatschek, Thomas; Erlandsson, Ann; Foukakis, Theodoros Journal: Oncoimmunology Issue: Volume 7:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen. (3rd April 2017) Authors: Rosell, Johan; Nordenskjöld, Bo; Bengtsson, Nils-Olof; Fornander, Tommy; Hatschek, Thomas; Lindman, Henrik; Malmström, Per-Olof; Wallgren, Arne; Stål, Olle; Carstensen, John Journal: Acta oncologica Issue: Volume 56:Number 4(2017) Page Start: 614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients. (7th September 2018) Authors: Sim, Sarah; Bergh, Jonas; Hellström, Mats; Hatschek, Thomas; Xie, Hanjing Journal: Pharmacogenomics Issue: Volume 19:Number 16(2018) Page Start: 1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗